New antibiotic could treat drug-resistant gonorrhea: Study
- A new oral antibiotic called gepotidacin could become the first new treatment for gonorrhea since the 1990s.
- A Phase 3 trial found gepotidacin to be as effective as the current leading antibiotic combination for treating gonorrhea, including drug-resistant cases.
- While mostly mild side effects like diarrhea and nausea were more common with gepotidacin, researchers call for further study in underrepresented groups.
53 Articles
53 Articles
Gonorrhea is on the verge of being impossible to treat, but a new antibiotic may alter that course
Rates of antibiotic-resistant gonorrhea have been on the rise across the globe. Reliable treatment for the sexually transmitted infection is down to one medication. This makes a new study showing a new antibiotic to be effective against gonorrhea particularly significant.
Hit: the first antibiotic discovered in 30 years arrives just in time to prevent supergonorrhea from becoming intractable
Gepotidacin eliminates sexually transmitted bacteria in 93 per cent of cases, in the midst of a global emergency due to the lack of new antimicrobials

New Antibiotic May Be Effective in Treating Gonorrhea
Key Takeaways
One of the most common sexually transmitted infections in Australia can now be tested at home
At-home rapid tests for sexually transmitted infections, chlamydia and gonorrhoea, are now available for women Australia-wide. There has been an increase in the STIs across the country - particularly gonorrhoea, which, globally is becoming more resistant to treatment. But scientists believe they've found an new effective antibiotic for the infection.
Coverage Details
Bias Distribution
- 48% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage